Recently, Congress approved a 5% increase in total spending on research and development, to $155.8 billion. Last year, the National Institute of Health (NIH) granted a big portion of this, more than $30 billion, to scientific researchers. However, even with such a large amount of taxpayer money being allocated to researchers who work in life science labs, they are still working in the dark. This is due to experimentation results coming in slowly, inefficient research processes, and a lack of transparency into insights from previous research — all causing a deceleration of drug discovery and finding of cures for diseases.
This article highlights the scope for developing therapeutics with new innovative, alternative approaches. The current trillion dollars pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention. The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways.
Watch this Video to understand how recent advances provide breakthrough technology for doing scalable modeling of complex molecular systems to dramatically accelerate drug discovery and development.